This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Ferrer Internacional, S.a., Fundacion Centro Nacional De Investigaciones Cardiovasculares Carlos III. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 48 
1 out of 1 Years Active: 2020
Title: Pablo Martin Sanz: Innovator in Cardiovascular Treatment
Introduction
Pablo Martin Sanz is a notable inventor based in Sant Cugat del Vallès, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular diseases. His innovative approach has led to the development of a unique oral formulation that combines two active agents for enhanced therapeutic efficacy.
Latest Patents
Pablo Martin Sanz holds 1 patent for his invention titled "Oral formulation for the treatment of cardiovascular diseases." This patent describes an orally administrable pharmaceutical dosage form designed for the prevention and/or treatment of cardiovascular diseases. The formulation includes acetylsalicylic acid as the first active agent and an HMG-CoA reductase inhibitor, specifically atorvastatin or rosuvastatin, as the second active agent. The invention is characterized by its unique coating, which consists of water-soluble polymers and a controlled percentage of water-insoluble or enteric polymers, ensuring an immediate release profile.
Career Highlights
Throughout his career, Pablo has worked with prominent organizations, including Ferrer Internacional, S.A. and Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III. His experience in these institutions has allowed him to refine his expertise in pharmaceutical research and development.
Collaborations
Pablo has collaborated with various professionals in the field, including his coworker Javier Urbano Hurtado. These partnerships have contributed to the advancement of his research and the successful development of his patented formulation.
Conclusion
Pablo Martin Sanz is a distinguished inventor whose work in cardiovascular treatment showcases his innovative spirit and dedication to improving healthcare. His contributions to pharmaceutical formulations are significant and reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile